Financial Management Professionals’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
Financial Management Professionals's XBI Position: Q3 2026 in Review
Financial Management Professionals reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 8.1% in Q3 2026, selling an estimated $154K and leaving 11,025 shares worth $1.74M. The position accounts for 0.16% of the portfolio, ranked #48.
Financial Management Professionals first reported a position in XBI in Q4 2017 and has held it in 28 quarters since. The position peaked at $3.1M in Q1 2018. 820 funds tracked by Wall St. Rank hold XBI as of Q3 2026.
- Financial Management Professionals held 11,025 shares of State Street SPDR S&P Biotech ETF worth $1.74M as of Q3 2026.
- Financial Management Professionals sold 975 State Street SPDR S&P Biotech ETF shares in Q3 2026, an estimated $154K.
- State Street SPDR S&P Biotech ETF made up 0.16% of Financial Management Professionals's portfolio in Q3 2026, its #48 holding.
- Financial Management Professionals first reported a position in State Street SPDR S&P Biotech ETF in Q4 2017 and has held it in 28 quarters since.
- Financial Management Professionals's State Street SPDR S&P Biotech ETF position peaked at $3.1M in Q1 2018.
- 820 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2026.
Based on Financial Management Professionals's 13F filing for Q3 2026, filed 23 Oct 2026.